Lau Joan 4

What Happened

• Joan Lau, a director of Rockwell Medical, was granted 9,633 restricted stock units (RSUs) on July 1, 2026. The award was reported as an acquisition at $0.00 per share (total immediate cash paid = $0). These RSUs represent a future right to receive common stock if vesting conditions are met.

Key Details

• Transaction date: July 1, 2026; Filing date: July 6, 2026 (note: Form 4s are generally due within two business days of the transaction, so this filing appears later than the usual deadline).
• Award: 9,633 RSUs, acquisition price $0.00 (reported value at grant = $0 immediate cash).
• Vesting: RSUs vest on July 1, 2027, subject to the reporting person’s continued service through the 2027 Annual Meeting (footnote).
• Reverse split: Effective 12:01 AM on July 1, 2026, the company completed a 1-for-10 reverse stock split; the filing notes share counts and outstanding equity awards were adjusted to reflect that split.
• Shares owned after the transaction: Not specified in the provided filing excerpt; the filing states reported amounts have been adjusted for the 1-for-10 reverse split.

Context

• This was an equity award (A = award/grant) rather than an open-market purchase or sale. Because these are restricted units that vest in the future subject to continued service, they do not reflect an immediate purchase of stock by the insider nor an immediate sale. Such grants are common for director compensation and are not, by themselves, a direct market signal to buy or sell.